The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

April 1, 2015 • By Jennifer Stichman, MD, and Dennis J. Boyle, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The most important thing we can do as practitioners is to remember that non-adherence is a prevalent problem and to ask our patients if and how they are taking their medications. If answers are discordant from available pharmacy data, one needs to address the discrepancy.

You Might Also Like
  • Personal Beliefs Affect Medication Adherence for RA Patients
  • Medication Adherence for Osteoporosis Prevention
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
Explore This Issue
April 2015

It’s easy in clinic visits to focus on side effects and disease control, but asking more open-ended questions, such as, “Do you have any concerns about your medications?” or “What might get in the way of you taking this medication?” might give a patient space to share whatever problem they are having.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A shift in physician mentality from non-adherence to shared decision making can be helpful in improving adherence to medication and improving disease control.


Jennifer Stichman, MD, is an assistant professor of general internal medicine at Denver Health and the University of Colorado.
Dennis J. Boyle, MD, is an associate professor of medicine and rheumatology at Denver Health and the University of Colorado.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Highlights & Tips

  • Medications only work when taken.
  • Rates of non-adherence are much higher than we think.
  • Non-adherence is associated with poor outcomes.
  • Non-adherence is an issue for patients from any socioeconomic background.
  • Ask patients in an open fashion how they take their medicines.
  • Do anticipatory problem solving around medications.
  • Explore patient worries and concerns about medications.
  • Use the teach-back method.
  • Write or print a med list at the end of every visit.
  • Enlisting the patient in their care is as important as making the correct diagnosis.

References

  1. DiMatteo MR. Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Med Care. 2004 Mar;42(3):200–209.
  2. Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: Analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010 Apr;25(4):284–290.
  3. Foster SA, Foley KA, Meadows ES, et al. Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance. Osteoporos Int. 2011 Feb;22(2):551–557.
  4. Reach G. Treatment adherence in patients with gout. Joint Bone Spine. 2011 Oct;78(5):456–459.
  5. Grijalva CG, Chung CP, Arbogast PG, et al. Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care. 2007;45(10 Suppl 2):S66–S76.
  6. Blum MA, Koo D, Doshi JA. Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: A systematic review. Clin Ther. 2011 Jul;33(7):901–913.
  7. Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health. 2007 Jul–Aug;10(4):231–237.
  8. van Hulst LT, Kievit W, van Bommel R, et al. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment. Arthritis Care Res (Hoboken). 2011 Oct;63(10):1407–1414.
  9. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Drug Updates, Rheumatoid Arthritis, Safety Tagged With: adherence, Boyle, Medication, patient care, rheumatology, StichmanIssue: April 2015

You Might Also Like:
  • Personal Beliefs Affect Medication Adherence for RA Patients
  • Medication Adherence for Osteoporosis Prevention
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • Gout Treatments Effective If Patients Maintain Lifelong Adherence to Therapies

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)